Leading research of DNA repair of the skin for more than 20 years, AGI Dermatics pharmaceutical labratory is the formulator of Remergent® skin care. Developed to fill critical voids in current skincare therapies, Remergent® products activate self-healing, reverse skin cell dysfunction, and maximize result for long-term gain through prevention, repair, and restoration.  

AGI has distinguished itself as the first commercial skincare lab to recognize that DNA damage suppresses the skin's immune function. AGI was also the first to demonstrate that DNA repair can preserve and restore healthy skin. Each of these breakthroughs - based on DNA science - is now considered fundamental to the future of genetic dermatology and skincare.

Being published in dozens of peer-reviewed scientific and medical journals as well as controlled clinical studies both validate AGI's application of groundbreaking active ingredients and meticulously engineered liposome delivery systems.